Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: A pilot study

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Park, Young Min ^a   Lee, Bun Hee ^b   Um, Tae Hyun ^a   Kim, Sollip ^a  

^a Inje University College of Medicine   (South Korea)

^b Eulji General Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN; SEROTONIN AGONIST; ZOLPIDEM;

ADULT; AGED; ARTICLE; ASIAN; BARRATT IMPULSIVENESS SCALE SCORE; BLOOD SAMPLING; BRAIN DERIVED NEUROTROPHIC FACTOR BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LOUDNESS; LOUDNESS DEPENDENCE OF AUDITORY EVOKED POTENTIAL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; PILOT STUDY; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; SUICIDE ATTEMPT; BLOOD; HEARING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMETRY;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; PILOT PROJECTS; PSYCHOMETRICS; SEROTONIN; SUICIDE, ATTEMPTED;

EID: 84899735562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091061     Document Type: Article

References (64)

1. Lee BH, Kim YK (2010) The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig 7: 231-235.
2. Lee BH, Kim H, Park SH, Kim YK (2007) Decreased plasma BDNF level in depressive patients. J Affect Disord 101: 239-244. (Pubitemid 46879923)
3. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, et al. (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20: 771-782. (Pubitemid 30225579)
4. Mamounas LA, Blue ME, Siuciak JA, Altar CA (1995) Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15: 7929-7939. (Pubitemid 26006900)
5. Lang UE, Hellweg R, Gallinat J (2005) Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 30: 1148-1153. (Pubitemid 40720973)
6. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33: 173-187. (Pubitemid 23089966)
7. Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62: 93-100. (Pubitemid 32126614)
8. Strobel A, Debener S, Schmidt D, Hunnerkopf R, Lesch KP, et al. (2003) Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 118B: 41-47. (Pubitemid 37064074)
9. Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, et al. (2003) Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64: 115-124. (Pubitemid 37412333)
10. Fitzgerald PB, Mellow TB, Hoy KE, Segrave R, Cooper NR, et al. (2009) A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression. J Affect Disord 117: 212-216.
11. Park YM, Lee SH (2013) Can the Loudness Dependence of Auditory Evoked Potentials and Suicidality Be Used to Differentiate between Depressive Patients with and without Bipolarity. Psychiatry Investig 10: 143-147.
12. Park YM, Lee SH, Kim S, Bae SM (2010) The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 34: 313-316.
13. O'Neill BV, Croft RJ, Nathan PJ (2008) The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol 23: 355-370.
14. Jaworska N, Blondeau C, Tessier P, Norris S, Fusee W, et al. (2013) Response prediction to antidepressants using scalp and source-localized loudness dependence of auditory evoked potential (LDAEP) slopes. Prog Neuropsychopharmacol Biol Psychiatry 44: 100-107.
15. Juckel G, Pogarell O, Augustin H, Mulert C, Muller-Siecheneder F, et al. (2007) Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 68: 1206-1212. (Pubitemid 47395622)
16. Mulert C, Juckel G, Brunnmeier M, Karch S, Leicht G, et al. (2007) Prediction of treatment response in major depression: integration of concepts. J Affect Disord 98: 215-225. (Pubitemid 46149060)
17. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, et al. (2000) The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 148: 404-411. (Pubitemid 30169759)
18. Mulert C, Juckel G, Augustin H, Hegerl U (2002) Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 113: 1566-1572. (Pubitemid 35283943)
19. Kim DH, Park YM (2013) The association between suicidality and serotonergic dysfunction in depressed patients. J Affect Disord 148: 72-76.
20. Park YM, Lee SH, Park EJ (2012) Usefulness of LDAEP to predict tolerability to SSRIs in major depressive disorder: a case report. Psychiatry Investig 9: 80-82.
21. Lee KS, Park YM, Lee SH (2012) Serotonergic dysfunction in patients with bipolar disorder assessed by the loudness dependence of the auditory evoked potential. Psychiatry Investig 9: 298-306.
22. Park YM, Kim DW, Kim S, Im CH, Lee SH (2011) The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology (Berl) 213: 625-632.
23. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
24. Beck AT, Weissman A, Lester D, Trexler L (1974) The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 42: 861-865.
25. Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768-774. (Pubitemid 26021724)
26. Maier W, Buller R, Philipp M, Heuser I (1988) The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 14: 61-68. (Pubitemid 18016383)
27. Beck AT, Kovacs M, Weissman A (1979) Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 47: 343-352. (Pubitemid 9157284)
28. Park KB, Shin MS (1991) Perceived stress and suicidal ideation of high school students. Korean J Clinical Psychology 10: 298-314.
29. Shin MS, Park KB, Oh KJ, Kim JS (1990) A study of suicidal ideation among high school students: the structural relation among depression, hopelessness, and suicidal ideation. Korean J Clinical Psychology 9: 1-19.
30. Chung YO, Lee CW (1997) A study of factor structures of the Barratt impulsiveness scale in Korean university students. Korean J Clin Psychol 16: 117-129.
31. Yi JS, Bae SO, Ahn YM, Park DB, Noh KS, et al. (2005) Validity and Reliability of the Korean Version of the Hamilton Depression Rating Scale(K-HDRS). J Korean Neuropsychiatr Assoc 44: 456-465.
32. Semlitsch HV, Anderer P, Schuster P, Presslich O (1986) A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23: 695-703. (Pubitemid 17014356)
33. Gudlowski Y, Ozgurdal S, Witthaus H, Gallinat J, Hauser M, et al. (2009) Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 109: 141-147.
34. Juckel G, Gudlowski Y, Muller D, Ozgurdal S, Brune M, et al. (2008) Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia-a replication study. Psychiatry Res 158: 79-82.
35. Brocke B, Beauducel A, John R, Debener S, Heilemann H (2000) Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 41: 24-30. (Pubitemid 30025908)
36. Hensch T, Herold U, Brocke B (2007) An electrophysiological endophenotype of hypomanic and hyperthymic personality. J Affect Disord 101: 13-26. (Pubitemid 46881262)
37. Linka T, Muller BW, Bender S, Sartory G (2004) The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett 367: 375-378. (Pubitemid 39178616)
38. Linka T, Muller BW, Bender S, Sartory G, Gastpar M (2005) The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry 38: 139-143. (Pubitemid 40965968)
39. Linka T, Sartory G, Bender S, Gastpar M, Muller BW (2007) The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord 103: 139-145. (Pubitemid 47445765)
40. Linka T, Sartory G, Wiltfang J, Muller BW (2009) Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression. Neurosci Lett 463: 26-30.
41. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, et al. (2010) Antidepressant drug effects and depression severity: a patient-level metaanalysis. JAMA 303: 47-53.
42. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, et al. (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5: e45.
43. Kim YK, Lee HP, Won SD, Park EY, Lee HY, et al. (2007) Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 31: 78-85.
44. Radka SF, Holst PA, Fritsche M, Altar CA (1996) Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 709: 122-301.
45. Lee BH, Kim YK (2009) Reduced platelet BDNF level in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 33: 849-853.
46. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, et al. (2002) Brainderived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87: 728-734. (Pubitemid 34302963)
47. Pliego-Rivero FB, Bayatti N, Giannakoulopoulos X, Glover V, Bradford HF, et al. (1997) Brain-derived neurotrophic factor in human platelets. Biochem Pharmacol 54: 207-209. (Pubitemid 27353239)
48. Mann JJ (1998) The neurobiology of suicide. Nat Med 4: 25-30.
49. Park YM, Lee SH (2013) Clinical Usefulness of Loudness Dependence of Auditory Evoked Potentials (LDAEP) in Patients with Bipolar Disorder. Psychiatry Investig 10: 233-237.
50. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12: 1079-1088.
51. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
52. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311: 864-868. (Pubitemid 43228853)
53. Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, et al. (2003) Brainderived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54: 994-1005. (Pubitemid 37415034)
54. Dias BG, Banerjee SB, Duman RS, Vaidya VA (2003) Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45: 553-563. (Pubitemid 36936988)
55. Miro X, Perez-Torres S, Artigas F, Puigdomenech P, Palacios JM, et al. (2002) Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43: 1148-1157. (Pubitemid 36009368)
56. Juckel G, Schumacher C, Giegling I, Assion HJ, Mavrogiorgou P, et al. (2010) Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene. J Psychiatr Res 44: 541-546.
57. Park YM, Lee SH, Lee HJ, Kang SG, Min JA, et al. (2013) Association between BDNF gene polymorphisms and serotonergic activity using loudness dependence of auditory evoked potentials in healthy subjects. PLoS One 8: e60340.
58. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455: 894-902.
59. Zarate C, Duman RS, Liu G, Sartori S, Quiroz J, et al. (2013) New paradigms for treatment-resistant depression. Ann N Y Acad Sci 1292: 21-31.
60. Zarate CA, Jr., Mathews DC, Furey ML (2013) Human biomarkers of rapid antidepressant effects. Biol Psychiatry 73: 1142-1155.
61. Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33: 73-83. (Pubitemid 350191318)
62. Rothman SM, Mattson MP (2013) Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan. Neuroscience 239: 228-240.
63. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, et al. (2013) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 18: 332-339.
64. Baer L, Blais MA (2010) Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. New York:Humana Press.